Fisayo A. Olotu

Across the blood-brain barrier: Neurotherapeutic screening and characterization of naringenin as a novel CRMP-2 inhibitor in the treatment of Alzheimer's disease using bioinformatics and computational tools

Maryam Lawal, Fisayo A. Olotu, Mahmoud E. S. Soliman · Computers in Biology and Medicine · 2018 · 68 citations

Medicine, Medicinal Chemistry, Pharmacology +17

From mutational inactivation to aberrant gain‐of‐function: Unraveling the structural basis of mutant p53 oncogenic transition

Fisayo A. Olotu, Mahmoud E. S. Soliman · Journal of Cellular Biochemistry · 2017 · 49 citations

Life Sciences, Genetics, Oncology +17

Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries

Lanlan Jing, Gaochan Wu, Xia Hao et al. · European Journal of Medicinal Chemistry · 2019 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +12

Probing Gallate-Mediated Selectivity and High-Affinity Binding of Epigallocatechin Gallate: a Way-Forward in the Design of Selective Inhibitors for Anti-apoptotic Bcl-2 Proteins

Fisayo A. Olotu, Clement Agoni, Emmanuel A. Adeniji et al. · Applied Biochemistry and Biotechnology · 2018 · 36 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17

Allosteric inhibition abrogates dysregulated LFA-1 activation: Structural insight into mechanisms of diminished immunologic disease

Maryam Abdullahi, Fisayo A. Olotu, Mahmoud E. S. Soliman · Computational Biology and Chemistry · 2018 · 28 citations

Life Sciences, Immunology, Medicinal Chemistry +14